This study investigates the laboratory parameters in patients with chronic cerebral ischemia (CCI) in relation to the presence of concomitant chronic obstructive pulmonary disease (COPD). CCI is characterized by a progressive reduction in cerebral blood flow, while COPD can exacerbate hypoxia, potentially worsening brain ischemia. The research evaluates blood biomarkers, including inflammatory markers and oxygenation indices, to determine the impact of COPD on CCI patients. Results suggest that patients with both CCI and COPD present with more severe inflammatory responses and lower oxygenation levels, which may influence the progression of cerebral ischemia and overall prognosis.

Chronic cerebral ischemia, chronic obstructive pulmonary disease, laboratory parameters

Vasilyeva O.S., Gusakov A.A., Gushchina E.E., Kravchenko N.Yu. Chronic obstructive pulmonary disease. Pulmonology, - 2013; -№3, -P,49 - 55.

Suslina Z.A., Varakin Yu.Ya., Vereshchagin N.V. Vascular diseases of the brain. - M .: MEDpress-inform, 2015. - 356 p.

Shumatov V.B., Nevzorova V.A. Clinical pathophysiology of systemic manifestations of chronic obstructive pulmonary disease. Vladivostok: Medicine DV, 2012. 232 p.

Chuchalin A.G., Avdeev S.N., Aysanov Z.R., Belevskiy A.S., Leshchenko I.V., Meshcheryakova N.N., Ovcharenko S.I., Shmelev E.I. Russian respiratory society. federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease// J. Pulmonologiya. -2014. -№3 -P.15-54. https://doi.org/10.18093/0869-0189-2014-0-3-15-54